Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

2015

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

38

References

49

Citations